• Quantified Patient

    Oct 21, 2013, 07:00 AM by Michael Croft
    Bio-IT World | Health care and the life sciences industry’s success ultimately turns on patient investment and compliance. No matter how brilliant the finding, how good the drug, how effective the treatment, it is only as good as the patient’s ability and willingness to participate.
    Full story
  • Alemtuzumab, My Dear Watson

    Oct 18, 2013, 14:00 PM by Michael Croft
    Forbes | Watson, the IBM supercomputer best known for its successful stint as a Jeopardy contestant, has a new gig as a clinical advisor at MD Anderson Cancer Center.
    Full story
  • 5 Ways Technology Is Changing Personalized Medicine

    Oct 18, 2013, 07:00 AM by Michael Croft
    Bio-IT World | Guest Commentary | In today’s doctor’s office, when a physician diagnoses a patient, a number of tests are consulted and the best possible course of treatment is prescribed. Unfortunately there is often limited data that allows the doctor to tailor and customize treatment specifically to a patient's biology and lifestyle. But there are five ways technology will change that over the next decade, bringing personalized medicine to fruition.
    Full story
  • Good Start's Test Detects More Carriers

    Oct 17, 2013, 12:00 PM by Michael Croft
    Bio-IT World News Brief | Good Start Genetics presented additional data on their GoodStart Select carrier screening test. GoodStart reports that 8.4% of carriers of genetic diseases detected with the Good Start tests would have been missed using other available technologies.
    Full story
  • Clinical Genomics, Informatics in Lisbon

    Oct 17, 2013, 08:00 AM by Michael Croft
    Bio-IT World | Bio-IT World is taking on Europe this December under a new name: Clinical Genomics & Informatics Europe. For our fifth year in Europe, we’re digging specifically into clinical genomics and the informatics that underlie progress. Our sequencing track will cover both clinical exome sequencing and RNA sequencing, and on the informatics side of the house, we’ll look at high-scale computing and genomic informatics. The program is rich with standout speakers. Here are just a few of the presentations we’ve flagged.
    Full story
  • Rare Recessive Disorder Hints at Crucial Role for 'Non-Essential' Protein

    Oct 16, 2013, 15:40 PM by Michael Croft
    Neuron | A team of researchers seeking to pinpoint the genetic cause of a rare disorder of brain growth have implicated deficiencies of the amino acid asparagine in the disease phenotype.
    Full story
  • OpenHelix Launches Free Bioinformatics Tools Tutorials for Mobile

    Oct 16, 2013, 12:00 PM by Michael Croft
    Bio-IT World News Brief | OpenHelix today launched a suite of over 100 online bioinformatics and genomics tutorials that introduce researchers, teachers, and students to biomedical resources that are freely available on the web.
    Full story
  • Apache Releases Hadoop 2

    Oct 16, 2013, 11:00 AM by Michael Croft
    Computerworld | The Apache Software Foundation has released Hadoop 2. The most notable new component is YARN--yet another resource negotiator--which Apache refers to as MapReduce version 2.
    Full story
  • Six Years After Acquisition, Roche Quietly Shutters 454

    Oct 16, 2013, 10:15 AM by Michael Croft
    Bio-IT World News Brief | This month, Roche began the process of closing its wholly-owned subsidiary 454 Life Sciences, a once-dominant player in next-generation sequencing.
    Full story
  • A Daughter's Data: More on 23andMe and Privacy

    Oct 16, 2013, 09:00 AM by Michael Croft
    FastCompany | In another 23andMe profile, an author submits a sample from her adopted daughter and gets some of the most challenging results.
    Full story
  • A New Method of Attack Against Cancer: Old Age

    Oct 15, 2013, 07:45 AM by Michael Croft
    Nature Communications | Researchers at the University of Massachusetts Medical School believe it may be possible to stop tumor cells from proliferating by teaching them how to age again.
    Full story
  • Changing the Terms of Antibiotic Discovery

    Oct 14, 2013, 08:00 AM by Michael Croft
    Nature Chemical Biology | Researchers from McMaster University are bypassing traditional drug discovery methods by targeting the processes through which bacteria synthesize and metabolize nutrients, hoping to find new antibiotic compounds that could destroy pathogens in vivo even though these drugs would not work in the ideal nutrient-rich conditions usually tested in the lab.
    Full story
  • Human Variome Project Expands in Southeast Asia

    Oct 11, 2013, 11:00 AM by Michael Croft
    Bio-IT World News Brief | The Human Variome Project has launched a Southeast Asian node to facilitate the sharing of genetic variations in Southeast Asian populations.
    Full story
  • MolecularHealth Enters the American Cancer Genomics Market

    Oct 11, 2013, 08:05 AM by Michael Croft
    Bio-IT World | MolecularHealth, which just announced the management team for its North American Office, is preparing to launch a personalized, direct-to-consumer genomic service for cancer patients in the Unites States.
    Full story
  • One Simple Rule Could Regulate Structural Neuroplasticity

    Oct 10, 2013, 17:10 PM by Michael Croft
    PLOS Computational Biology | Researchers have proposed a simple homeostatic rule to explain the process by which new neural connections are established and damage to the brain is repaired.
    Full story
  • Genetic Witnesses to European Prehistory

    Oct 10, 2013, 14:15 PM by Michael Croft
    Science | A large study of ancient mitochondrial DNA is helping to reconstruct the migration patterns of Europeans during the transition from hunter-gatherer to agricultural lifestyles.
    Full story
  • Lilly Scientists Steal Trade Secrets

    Oct 10, 2013, 07:00 AM by Michael Croft
    Indianapolis Business Journal | Two Lilly scientists emailed details about nine experimental drug research programs to an individual employed by Jiangsu Hengrui Medicine Co. Ltd., based in China.
    Full story
  • A New Round of Fundraising for Oxford Nanopore

    Oct 9, 2013, 13:30 PM by Michael Croft
    Bio-IT World News Brief | Oxford Nanopore Technologies Ltd. today announced $64 million in new funds, raised from a multinational mix of current and new investors.
    Full story
  • Our Genomes Are Talking to Us - Are We Good Listeners?

    Oct 8, 2013, 15:15 PM by Michael Croft
    Bio-IT World | Two large-scale surveys, the Coriell Personalized Medicine Collaborative and the Impact of Personal Genomics Study, have been peering into consumer responses to genomic test results. Now they're delivering insights into the mindsets and health behaviors of patients who seek out whole genome sequencing.
    Full story
  • September News and Product Briefs

    Oct 8, 2013, 08:50 AM by Michael Croft
    Bio-IT World | News briefs and product releases from around the industry, including BGI's American expansion, Virtify's streamlined process for submitting clinical trials, new software for measuring gene expression and hardware for live cell assays, and much more.
    Full story